For Jesse and his parents Clayton and Lee-Ann, the road ahead is not a single procedure, but a long, carefully managed medical journey that will unfold over months. It is a journey shaped by uncertainty, vigilance, and courage, and one that requires extraordinary medical care alongside unwavering family support.

At leading centres in Germany and at the National Institutes of Health (NIH) in Washington, preparation for a DOCK8 stem cell transplant is treated as just as important as the transplant itself. What follows is a clear, human picture of what this road typically looks like and why support remains so essential throughout. 

Below is an overview of how preparation typically works at specialist transplant centres and within NIH clinical protocols.

 

1. Understanding Jesse’s starting point. Comprehensive disease mapping — beyond the diagnosis

Before a child is even scheduled for transplant, teams build a full picture of disease burden.

This includes:

  • Genetic confirmation of the DOCK8 mutation
  • Detailed immune profiling (T-cell, B-cell, NK-cell function)
  • Viral load assessment (including chronic viral skin disease such as severe molluscum contagiosum)
  • Lung imaging and pulmonary function testing
  • Evaluation of prior infections and antibiotic resistance
  • Nutritional status and growth
  • Organ function (liver, kidneys, heart)

At centres such as NIH and Germany, this phase is deliberately slow and thorough. DOCK8 is not treated as a “standard transplant indication”. Every detail matters because pre-existing viral disease and organ damage strongly influence transplant risk and recovery.

Severe molluscum, like that affecting Jesse and Sadie, is not dismissed as a skin issue. It is recognised as a marker of profound immune dysfunction and ongoing viral burden, which must be factored into transplant timing and preparation.

 

2. Donor and transplant planning — complex by design

Once Jesse’s condition has been fully mapped, transplant planning moves forward. Centres do not treat donor selection as a binary “matched or not” question. Instead, they consider:

  • Degree of HLA match
  • Donor health and availability
  • Urgency of transplant
  • Viral burden and immune instability
  • Centre experience with different donor types

Importantly, donor availability does not reduce transplant risk. Even when a suitable donor is identified, DOCK8 transplants remain complex, particularly when viral disease is active.

The donor choice directly influences:

  • Conditioning intensity
  • Graft-versus-host disease (GVHD) prevention strategy
  • Post-transplant immune suppression
  • Infection prophylaxis

At the NIH and major German centres, these decisions are made by multidisciplinary teams, often involving immunologists, transplant physicians, infectious disease specialists, dermatologists, and pulmonologists. Each step is weighed carefully, because small decisions can have long-term consequences.

 

3. Stabilisation and infection control before transplant

One of the most important phases, and one that supporters often never see, is pre-transplant stabilisation. In this phase, Jesse’s care focuses on:

  • Reduce bacterial and fungal burden
  • Control active viral disease as much as possible
  • Treat secondary bacterial infections from chronic skin lesions
  • Optimise skin integrity
  • Improve nutritional reserves
  • Reduce inflammation before conditioning begins

Children with severe molluscum often require ongoing skin care, antimicrobial support, and close monitoring right up until transplant admission. For parents, it means living in a state of permanent readiness, knowing that plans can change quickly depending on how a child responds. This phase can take weeks or months, depending on how the child responds. This is not delay, it is risk reduction.

 

4. Conditioning: tailored, not generic

When Jesse is admitted for transplant, the pace intensifies. Conditioning treatment is given to prepare his body to accept donor stem cells. In DOCK8, this is tailored carefully: strong enough to allow successful engraftment, but balanced to avoid unnecessary toxicity. The transplant itself (the infusion of stem cells) is often described as anticlimactic. It looks simple. But the days and weeks around it are anything but.

Conditioning refers to the chemotherapy and immune-modulating treatment given before transplant to allow donor stem cells to engraft. In DOCK8, centres aim for enough conditioning to ensure durable engraftment, while carefully avoiding unnecessary toxicity. This balance is critical in non-malignant diseases.

Factors influencing conditioning choice include:

  • Child’s age and size
  • Viral burden and skin disease severity
  • Lung health
  • Donor type
  • Prior immune suppression
  • Centre-specific experience and published outcomes

There is no single “DOCK8 conditioning regimen.” Instead, protocols are individualised, drawing on EBMT/ESID guidance and centre expertise. This is also where timelines and costs can change, not because of miscalculation, but because every immune system rebuilds differently.

 

5. Hospital admission and transplant phase

Once admitted, the transplant process becomes highly structured. This phase typically includes:

  • Protective isolation
  • Central venous access
  • Conditioning chemotherapy
  • Stem cell infusion
  • Intensive monitoring for infection
  • Blood product support
  • Management of fevers, mucositis, skin reactions, and gut symptoms

The actual stem cell infusion may appear simple, but the surrounding weeks are medically intense. Children with DOCK8 are monitored closely for:

  • Early infections
  • GVHD
  • Delayed immune recovery
  • Reactivation of viral disease

After transplant, recovery is gradual. Jesse’s immune system will need time to rebuild, learn, and strengthen.

 

6. Immune reconstitution and early recovery

Post-transplant, the immune system does not “switch on” overnight. German and NIH protocols involve:

  • Gradual reduction of immune suppression
  • Ongoing antiviral, antifungal, and antibacterial prophylaxis
  • Frequent immune function testing
  • Monitoring for GVHD
  • Careful management of skin and viral disease as the new immune system develops
  • Clearance of chronic viral infections — including molluscum — is often a key sign of immune recovery, but it can take time.

Families are supported through prolonged periods of isolation, frequent clinic visits, and ongoing uncertainty during this phase.

 

7. Long-term follow-up: transplant is not the finish line

Even once Jesse leaves the hospital, the journey continues. Both German centres and NIH emphasise that HSCT is the beginning of a new phase, not the end of care.

Long-term follow-up includes:

  • Immune monitoring
  • Revaccination schedules
  • Lung surveillance
  • Skin and allergy management
  • Growth and development support
  • Psychosocial care for the child and family

This long arc of recovery is why transplant planning always includes post-transplant resources, not just the hospital stay.

A grounded perspective

Preparation for a DOCK8 transplant is not about bureaucracy or caution for its own sake. It is about giving a child the strongest possible foundation before undergoing one of the most demanding procedures in medicine. German centres and the NIH share this philosophy: careful preparation improves survival, reduces complications, and protects the future that transplant is meant to give. This is why planning takes time and why support matters at every stage of the journey.  

For Clayton and Lee-Ann, this journey means months away from home, constant medical decision-making, and the emotional weight of watching a child endure something no child should have to face, as well as the planning of Sadie’s treatment which will follow. Support during this time is not just financial. It is practical, emotional, and spiritual. It is knowing that others are holding the family in their thoughts and prayers while they focus entirely on Jesse’s care.

This road is demanding, unpredictable, and deeply personal. But it is also a road walked with hope grounded in expert medicine, careful preparation, and the belief that Jesse deserves a future defined by health, not illness.

As this next chapter begins, the family needs continued support more than ever.

References & Further Reading